We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$668M
AUM Growth
-$130M
Cap. Flow
-$43.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
87.83%
Holding
33
New
11
Increased
4
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$24.3M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$13.8M
3
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
+$11.9M
4
CAPR icon
Capricor Therapeutics
CAPR
+$11.5M
5
YMAB
Y-mAbs Therapeutics
YMAB
+$10.4M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$124M
2
PACB icon
Pacific Biosciences
PACB
+$9.63M
3
AGEN
Agenus
AGEN
+$9.13M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$6.32M
5
SLNO
Soleno Therapeutics
SLNO
+$3.31M

Sector Composition

Rank Sector Weight
1 Healthcare 99.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMTK
26
PUT
DELISTED
DermTech, Inc. Common Stock
DMTK
$356K 0.05%
+46,900
New +$2.45M
VIR icon
27
PUT
Vir Biotechnology
VIR
$1.49B
$221K 0.03%
+19,000
New +$1.02M
BHVN
28
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$17K ﹤0.01%
+33,600
New +$2.72M
QDEL icon
29
CALL
QuidelOrtho
QDEL
$838M
– –
-119,700
Closed -$1.08M
WBA
30
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-200,400
Closed -$203K
BIOL
31
DELISTED
Biolase, Inc.
BIOL
– –
-696
Closed -$725K
TBIO
32
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-100,000
Closed -$1.84M
BHVN
33
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-100,000
Closed -$400K
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Oracle Investment Management held 33 positions worth $668M, down 16% from $798M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management withdrew a net $43.4M in Q1 2021, closing 5 positions and reducing 10 holdings. Its most notable exit was Translate Bio, Inc. Common Stock, an estimated $1.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

Against the trend, Oracle Investment Management opened a new position in Vir Biotechnology worth $23.1M.

  • Oracle Investment Management's largest Q1 2021 buy was Vir Biotechnology: 450,331 shares worth $23.1M.
  • Oracle Investment Management added most to DermTech, Inc. Common Stock in Q1 2021, an estimated $13.8M increase.
  • Oracle Investment Management's biggest Q1 2021 reduction was QuidelOrtho, cutting an estimated $124M.
  • Oracle Investment Management fully exited Translate Bio, Inc. Common Stock in Q1 2021, selling an estimated $1.84M.
  • Oracle Investment Management's ten largest holdings make up 88% of its $668M portfolio in Q1 2021.
  • Oracle Investment Management opened 11 new positions and closed 5 in Q1 2021.
  • Oracle Investment Management's portfolio value fell 16% quarter-over-quarter to $668M.

Based on Oracle Investment Management's 13F filing for Q1 2021, filed 17 May 2021.